Test
Rapidly detect and differentiation between SARS-CoV-2, Flu A, and Flu B from one sample on one assay in 15 minutes with the newest BD Veritor assay.
Uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. Allows for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
The cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B.
Promotional kit for rapid detection and differentiation of SARS-CoV-2 and Influenza
The TaqPath COVID-19, Flu A, Flu B Combo Kit includes the assays and controls for a multiplex real-time RT-PCR test for the qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A, and influenza B viruses in nasopharyngeal and anterior nasal swabs from individuals suspected of COVID-19 by their healthcare provider.
OSOM Flu SARS-CoV-2 Combo Test is a lateral flow in vitro diagnostic for rapid and simultaneous detection and differentiation of influenza A, influenza B, and SARS-CoV-2 antigens for Healthcare providers. For Emergency Use Authorization Only.
The cobas™ liat SARS-CoV-2, Influenza A/B and RSV nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, Influenza B and RSV in nasopharyngeal or anterior nasal swab specimens.
The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay. Control kit includes three positive and three negative controls.
Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens, and oral fluids during the acute phaseof infection. Positive results are indicative of the presence of SARS-CoV-2 RNA. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.Negative results do not preclude SARS-CoV-2 infection and should not be the sole basis of a patient treatment/management or public health decision.The Quick SARS-CoV-2 Multiplex Kit is intended for use by personnel specifically instructed and trained in the techniques of real-time RT-PCR assays.
NC3238508 GLP1-C29-CP3 L-GA273
Reagent Kit Xpert® Xpress Real Time RT-PCR SARS-CoV-2 / Flu / RSV Plus For use with GeneXpert Xpress System for Point-of-Care / For use with GeneXpert Dx or GeneXpert Infinity System for Lab 10 Tests
23-264-819 STATUS COV/FLU AB KT 25TST/PK
LEGENDplex™ SARS-CoV-2 Neut. Ab Assay (1-plex) w/ FP Apps: Multiplex - Panel; Size: 100 tests
LEGENDplex™ SARS-CoV-2 Serological IgA Panel (2-plex) w/VbP Apps: Multiplex - Panel; Size: 100 tests